Bill

Bill > HB28


MD HB28

MD HB28
Pharmacists - Nicotine Replacement Therapy Medication


summary

Introduced
01/12/2022
In Committee
03/31/2022
Crossed Over
03/21/2022
Passed
04/07/2022
Dead
Signed/Enacted/Adopted
05/12/2022

Introduced Session

2022 Regular Session

Bill Summary

Pharmacists - Aids for the Cessation of Tobacco Product Use

AI Summary

This bill allows pharmacists in Maryland to prescribe and dispense nicotine replacement therapy (NRT) medications approved by the U.S. Food and Drug Administration (FDA) as an aid for the cessation of tobacco product use. The bill requires the Maryland Board of Pharmacy to adopt regulations by September 1, 2023, establishing standard procedures for pharmacists to follow when prescribing and dispensing NRT medications, as well as the conditions under which pharmacists can do so. Pharmacists must complete a training program approved by the Board, except for those who have already received such training as part of their formal education program.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Approved by the Governor - Chapter 319 (on 05/12/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...